tigemonam

{{chembox

| Verifiedfields = changed

| Watchedfields = changed

| verifiedrevid = 444385753

| ImageFile=Tigemonam.svg

| ImageSize=250px

| IUPACName=2-[[1-(2-Amino-1,3-thiazol-4-yl)- 2-[[(3S)-2,2-dimethyl-4-oxo-1- sulfooxyazetidin-3-yl]amino]-2- oxoethylidene]amino]oxyacetic acid

| OtherNames= Tigemen

|Section1={{Chembox Identifiers

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = 82H1LDS5D0

| CASNo_Ref = {{cascite|correct|??}}

| CASNo=102507-71-1

| PubChem=9576769

| SMILES=CC1([C@@H](C(=O)N1OS(=O)(=O)O)NC(=O)/C(=N\OCC(=O)O)/C2=CSC(=N2)N)C

| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}

| ChemSpiderID = 7851210

| InChI = 1/C12H15N5O9S2/c1-12(2)8(10(21)17(12)26-28(22,23)24)15-9(20)7(16-25-3-6(18)19)5-4-27-11(13)14-5/h4,8H,3H2,1-2H3,(H2,13,14)(H,15,20)(H,18,19)(H,22,23,24)/b16-7-/t8-/m1/s1

| InChIKey = VAMSVIZLXJOLHZ-QWFSEIHXBK

| StdInChI_Ref = {{stdinchicite|changed|chemspider}}

| StdInChI = 1S/C12H15N5O9S2/c1-12(2)8(10(21)17(12)26-28(22,23)24)15-9(20)7(16-25-3-6(18)19)5-4-27-11(13)14-5/h4,8H,3H2,1-2H3,(H2,13,14)(H,15,20)(H,18,19)(H,22,23,24)/b16-7-/t8-/m1/s1

| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}

| StdInChIKey = VAMSVIZLXJOLHZ-QWFSEIHXSA-N

}}

|Section2={{Chembox Properties

| C=12|H=15|N=5|O=9|S=2

| Appearance=

| Density=

| MeltingPt=

| BoilingPt=

| Solubility=

}}

|Section3={{Chembox Hazards

| MainHazards=

| FlashPt=

| AutoignitionPt =

}}

}}

Tigemonam is a monobactam antibiotic.{{cite journal |vauthors=Fuchs PC, Jones RN, Barry AL |title=In vitro antimicrobial activity of tigemonam, a new orally administered monobactam |journal=Antimicrob. Agents Chemother. |volume=32 |issue=3 |pages=346–9 |date=March 1988 |pmid=3259122 |pmc=172173 |doi= 10.1128/aac.32.3.346|url=}}{{cite journal |vauthors=Chin NX, Neu HC |title=Tigemonam, an oral monobactam |journal=Antimicrob. Agents Chemother. |volume=32 |issue=1 |pages=84–91 |date=January 1988 |pmid=3279906 |pmc=172104 |doi= 10.1128/aac.32.1.84|url=}}